Breaking News Instant updates and real-time market news.

WYNN

Wynn Resorts

$105.49

4.51 (4.47%)

, ADSK

Autodesk

$135.71

12.72 (10.34%)

09:55
11/21/18
11/21
09:55
11/21/18
09:55

Early notable gainers among liquid option names on November 21st

Notable gainers among liquid option names this morning include Foot Locker (FL) $53.00 +6.89, Autodesk (ADSK) $133.79 +10.70, Wynn Resorts (WYNN) $106.11 +5.09, Newfield Exploration (NFX) $18.49 +0.81, and Deere (DE) $144.45 +5.88.

WYNN

Wynn Resorts

$105.49

4.51 (4.47%)

ADSK

Autodesk

$135.71

12.72 (10.34%)

FL

Foot Locker

$53.00

6.9 (14.97%)

NFX

Newfield Exploration

$18.22

0.55 (3.11%)

DE

Deere

$143.50

5.01 (3.62%)

  • 21

    Nov

  • 26

    Nov

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

WYNN Wynn Resorts
$105.49

4.51 (4.47%)

11/21/18
DBAB
11/21/18
NO CHANGE
DBAB
Buy
Wynn Resorts shares set up well to outperform, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli believes Wynn Resorts management was prudent to reset the bar lower "during a period in which heroism is hardly being rewarded in gaming." The analyst finds the guidance conservative, which he thinks sets up shares of Wynn Resorts well to outperform, relative to peers. Santarelli keeps a Buy rating on the name.
11/15/18
BERN
11/15/18
INITIATION
Target $166
BERN
Outperform
Wynn Resorts initiated with an Outperform at Bernstein
Bernstein analyst Vitaly Umansky started Wynn Resorts with an Outperform rating and $166 price target. The analyst notes that over the last five years, gaming stocks have gone through periods of significant underperformance, followed by significant outperformance. The last six months have been exceptionally difficult for gaming stocks as Macau growth has begun to decelerate following nearly two years of strong growth and Las Vegas has seen unexpected near-term softness, he contends. However, Umansky argues that the gaming space has shown that if investors pick the right market, the right company, at the right time, outsized returns are possible.
11/08/18
ROTH
11/08/18
NO CHANGE
Target $140
ROTH
Buy
Wynn Resorts price target lowered to $140 from $210 at Roth Capital
Roth Capital analyst David Bain lowered his price target for Wynn Resorts (WYNN) to $140 from $210 as he believes Q4 Macau EBITDA guidance of between $304M-$340M versus $400M consensus exposes VIP/high-end play volatility in Macau and downside risks in the current China economy. While Wynn is the most exposed to VIP weakness in Macau, the analyst believes commentary stops the small momentum other Macau names were beginning to build since Las Vegas Sands (LVS) and MGM Resorts (MGM) reported earnings. He reiterates a Buy rating on Wynn's shares.
11/08/18
JEFF
11/08/18
NO CHANGE
Target $114
JEFF
Hold
Wynn Resorts price target lowered to $114 from $170 at Jefferies
Jefferies analyst David Katz lowered his price target for Wynn Resorts to $114 saying the company's "roughly in-line" quarter was overshadowed by pessimistic commentary on the high end of the Macau market. While the pressures may be temporary, historically, limited visibility in Macau warrants a conservative stance on estimates and valuation going forward, Katz tells investors in a post-earnings research note. He keeps a Hold rating on Wynn Resorts.
ADSK Autodesk
$135.71

12.72 (10.34%)

11/21/18
MUFG
11/21/18
NO CHANGE
Target $76
MUFG
Underweight
Autodesk price target raised to $76 from $64 at MUFG
MUFG analyst Stephen Bersey raised his price target for Autodesk to $76 after the company's Q3 results topped his estimates. Autodesk had a solid quarter, as revenue, annualized recurring revenue , and annualized revenue per subscription "exhibited momentum," Bersey tells investors in a post-earnings research note. The analyst also thinks the acquisition of PlanGrid should complement the company's BIM360 product offering. However, Bersey continues to have questions about the longer-term growth prospects of Autodesk and "potentially its continued reliance on acquisitions to help drive growth." He keeps an Underweight rating on the shares.
09/20/18
ADAM
09/20/18
NO CHANGE
Target $180
ADAM
Buy
Autodesk price target raised to $180 from $165 at Canaccord
Canaccord analyst Richard Davis raised his price target on Autodesk to $180 from $165 after meeting with management. The analyst said investors dialogue has changed for the better as the focus now seems to be on longer-term, strategic topics including the opportunity in construction, digitization of operations, sales alignment, and the value creation that accompanies full subscription adoption. Davis reiterated his Buy rating on Autodesk shares.
08/29/18
BARD
08/29/18
NO CHANGE
Target $165
BARD
Outperform
Autodesk Fresh Pick designation removed at Baird
Baird analyst Rob Oliver removed the Fresh Pick designation from Autodesk, but he remains bullish longer-term. The removal was made following its share price appreciation, but he said he has increased confidence in its long-term cash flow projections. He said he would use any weakness to accumulate or add to positions. Oliver maintained his Outperform rating and $165 price target on Autodesk shares.
11/21/18
OPCO
11/21/18
NO CHANGE
Target $160
OPCO
Outperform
Autodesk price target lowered to $160 from $175 at Oppenheimer
Oppenheimer analyst Koji Ikeda lowered his price target for Autodesk to $160 from $175 on group multiples compression. The analyst believes the company's Q3 results are another data point that Autodesk's products are entrenched and considered strategic in its end-markets. He reiterates an Outperform rating on the shares.
FL Foot Locker
$53.00

6.9 (14.97%)

11/21/18
WELS
11/21/18
NO CHANGE
Target $64
WELS
Outperform
Foot Locker price target raised to $64 from $58 at Wells Fargo
Wells Fargo analyst Tom Nikic raised his price target for Foot Locker (FL) to $64 from $58 and reiterated an Outperform rating on the shares. The analyst believes Foot Locker's turnaround story continues to pick up steam, as he thinks the Q3 print alleviated many of the concerns that have weighed on the shares this year. Nikic continues to view Foot Locker as a "very compelling turnaround story," driven by improving product flows, strong relationships with their key vendors such as Nike (NKE), a capable management team that has shown an ability to quickly adapt to changing market conditions, and a stock that is still fairly inexpensive.
11/21/18
JEFF
11/21/18
NO CHANGE
Target $62
JEFF
Buy
Jefferies says Foot Locker 'back on its feet,' boosts target to $62
Jefferies analyst Janine Stichter proclaims Foot Locker is "back on its feet" after the company reported upside in Q3 to both sales and margins. The analyst sees a case for both earnings upside and multiple expansion as "confidence in the top-line sustainability is restored." She raised her price target for Foot Locker shares to $62 from $60 and keeps a Buy rating on the name Foot Locker remains Stichter's favorite way to play Nike's (NKE) resurgence in North America.
11/21/18
ADAM
11/21/18
NO CHANGE
Target $64
ADAM
Buy
Foot Locker recovery thesis playing out, says Canaccord
Canaccord analyst Camilo Lyon noted Foot Locker reported solid Q3 results and said the beat was high quality. He was particularly pleased with the inflection in footwear and Europe as it benefited from the breadth and depth of on-trend platforms that resulted in an improving inventory mix. Lyon believes the results show his recovery thesis is playing out. He reiterated his Buy rating and raised his price target to $64 from $63 on Foot Locker shares.
11/21/18
FBCO
11/21/18
NO CHANGE
Target $63
FBCO
Outperform
Foot Locker price target raised to $63 from $56 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for Foot Locker (FL) to $63 from $56 following quarterly results as he believes the company proved out the accelerating same-store sales story. The analyst thinks Q3 goes a long way to proving Foot Locker can comp alongside Nike's (NKE) DTC aspirations. Binetti reiterates an Outperform rating on Foot Locker's shares.
NFX Newfield Exploration
$18.22

0.55 (3.11%)

11/05/18
11/05/18
DOWNGRADE

Equal Weight
Encana downgraded to Equal Weight on Newfield deal risk at Morgan Stanley
As previously reported, Morgan Stanley analyst Benny Wong downgraded Encana (ECA) to Equal Weight from Overweight, stating that he gives 50% credit to the targeted $250M in synergies the company outlined in its announcement of its deal to buy Newfield Exploration (NFX), but not the other half since Encana's Cube approach has not been tried before in the STACK/SCOOP play. The OKC play comes with concern around inventory quality and higher gas-oil ratios, added Wong, who now views Encana as a "show me" story. He lowered his price target on Encana shares to $15 from $19 and also raised his price target on Newfield shares to $31 to $23.
11/05/18
BMOC
11/05/18
DOWNGRADE
Target $12
BMOC
Market Perform
Encana downgraded to Market Perform at BMO Capital on Newfield deal
As reported earlier, BMO Capital analyst Randy Ollenberger downgraded Encana (ECA) to Market Perform from Outperform and lowered his price target to $12 from $18. The analyst says the company's "solid" Q3 results were "overshadowed" by its proposed $7.7B acquisition of Newfield Exploration (NFX) that produced a "material selloff" in its stock price, reflecting investors concerns over the "asset base and a shift in the underlying investment thesis" of the latter. Ollenberger contends that while the sell-off may be overdone, he expects the stock price to trade range-bound until more visibility over the benefits of the deal emerge.
11/02/18
SBSH
11/02/18
DOWNGRADE
SBSH
Neutral
Newfield Exploration downgraded to Neutral from Buy at Citi
Citi analyst Robert Morris downgraded Newfield Exploration (NFX) to Neutral to reflect the takeover by Encana (ECA). The analyst believes Newfield's decision to sell to a larger, more diversified Exploration & Production company at this stage as the right one.
11/02/18
SUSQ
11/02/18
DOWNGRADE
SUSQ
Neutral
Newfield Exploration downgraded to Neutral from Positive at Susquehanna
DE Deere
$143.50

5.01 (3.62%)

10/08/18
SBSH
10/08/18
NO CHANGE
SBSH
Citi opens 90-day positive catalyst watch on Caterpillar, Deere
Citi analyst Timothy Thein opened a 90-day positive catalyst watch on both Caterpillar (CAT) and Deere (DE) saying he sees several positive factors aligning that help to support near-term outperformance for the Machinery/Diversified Industrial stocks in to at least year-end. Recent back-up in rates, particularly in real terms and for longer durations, may reflect even stronger U.S. growth prospects, Thein tells investors in a research note. The analyst believes history suggests that rising Treasury yields favor cyclicals over defensives. Further, a spike in construction within China's services PMI suggest an infrastructure recovery is beginning to take hold, Thein contends.
10/09/18
BMOC
10/09/18
NO CHANGE
Target $195
BMOC
Outperform
BMO Capital positive on Deere optimization of farming jobs
BMO Capital analyst Joel Tiss kept his Outperform rating and $195 price target on Deere following investor meetings with its management last week that gave him better understanding of the company's ability to nearly double the price of its agriculture equipment. The analyst cites the company's focus on "optimizing farmers' jobs versus simply enhancing the mechanical side of the equipment", yielding a much smaller decline in large tractor sales from the 2013 peak than the 60% dropoff experienced in the industry. Tiss is also positive on Deere's subscription revenue initiatives that allows farmers to use databases to maximize yields and productivity as well as the building strength in the ag market in spite of the crop prices remaining depressed.
11/15/18
DBAB
11/15/18
NO CHANGE
DBAB
Hold
Deere may be later in cycle than it appears, says Deutsche Bank
Deutsche Bank analyst Chad Dillard says his channel checks with several dealers left him thinking that Deere might be later in the cycle than it appears. Large agriculture volumes will be flat in 2019 versus expectations of a modest increase, used combine inventories are ticking up again and farmer sentiment has softened, Dillard tells investors in a research note. With this backdrop, the analyst expects Deere to "guide conservatively" into 2019. With the shares trading at a 31% premium to its peers, the market "appears off-side on this stock going into earnings," Dillard writes. While he's "tactically cautious" over the near term, he views Deere's risk/reward as balanced over the longer term. The analyst keeps a Hold rating on the shares.
09/24/18
DBAB
09/24/18
NO CHANGE
DBAB
Buy
Agco shares well positioned to outperform, says Deutsche Bank
Deutsche Bank analyst Chad Dillard believes shares of Agco (AGCO) are well positioned to outperform with expectations "near rock-bottom levels." The analyst spent time in Europe with Deere's (DE) head of sales/marketing for EAME and left with incrementally positive read-throughs for Agco. The impact of the drought on farmers is not as bad as feared and revenues for that region could be up 6%-7%, which could translate into 5%-10% upside to 2019 earnings expectations, Dillard tells investors in a research note. He keeps a Buy rating on Agco.

TODAY'S FREE FLY STORIES

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

, GOV

Government Properties

$7.68

-0.41 (-5.07%)

17:08
12/15/18
12/15
17:08
12/15/18
17:08
Conference/Events
Select Income REIT to host special shareholder meeting »

Special Shareholder…

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

GOV

Government Properties

$7.68

-0.41 (-5.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

GOV

Government Properties

$7.68

-0.41 (-5.07%)

, SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

17:06
12/15/18
12/15
17:06
12/15/18
17:06
Conference/Events
Government Properties to host special shareholder meeting »

Special Shareholder…

GOV

Government Properties

$7.68

-0.41 (-5.07%)

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

12:37
12/15/18
12/15
12:37
12/15/18
12:37
Periodicals
U.S. stocks could rally about 10% in 2019, Barron's says »

As U.S. stocks stumble…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

, ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

12:21
12/15/18
12/15
12:21
12/15/18
12:21
Periodicals
Alphabet, Apple among top stock picks for 2019, Barron's says »

Even if investors have…

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

DDAIF

Daimler AG

$0.00

(0.00%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

BAC

Bank of America

$24.49

0.1 (0.41%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 12

    Feb

  • 03

    Mar

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

08:26
12/15/18
12/15
08:26
12/15/18
08:26
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

F

Ford

$8.53

0.025 (0.29%)

GM

General Motors

$35.10

-0.01 (-0.03%)

HMC

Honda

$26.90

-0.33 (-1.21%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$120.06

-0.83 (-0.69%)

VLKAY

Volkswagen

$0.00

(0.00%)

TSLA

Tesla

$365.69

-11.17 (-2.96%)

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Oclaro

$8.27

(0.00%)

FNSR

Finisar

$21.74

-0.4 (-1.81%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.14

-0.095 (-2.25%)

CIEN

Ciena

$34.55

-0.35 (-1.00%)

GOOS

Canada Goose

$52.18

-2.48 (-4.54%)

FDX

FedEx

$184.08

-3.13 (-1.67%)

UPS

UPS

$98.67

-2.1 (-2.08%)

AMZN

Amazon.com

$1,592.14

-67.86 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 07

    Jan

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/15/18
12/15
04:55
12/15/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

TEVA

Teva

$18.46

-0.56 (-2.94%)

18:34
12/14/18
12/14
18:34
12/14/18
18:34
Hot Stocks
Teva, Celltrion announce FDA approval of HERZUMA »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$7.43

(0.00%)

18:11
12/14/18
12/14
18:11
12/14/18
18:11
Hot Stocks
Pretium Resources: Brucejack approved for production hike to 3,800 tonnes/day »

Pretium Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

17:52
12/14/18
12/14
17:52
12/14/18
17:52
Periodicals
FCA says four U.S. plants to have down-time in January, Detroit News says »

Fiat Chrysler said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

, CCNI

Command Center

$4.00

-0.075 (-1.84%)

17:43
12/14/18
12/14
17:43
12/14/18
17:43
Hot Stocks
Sonoma Pharmaceuticals CEO Jim Schutz resigns, Frederick Sandford succeeds »

Sonoma Pharmaceuticals…

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

CCNI

Command Center

$4.00

-0.075 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

, XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

17:38
12/14/18
12/14
17:38
12/14/18
17:38
General news
Week ending ETF scorecard: Energy, Financials lead the decline »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

IYR

DJ US Real Estate Index Fund

$80.37

-0.14 (-0.17%)

XLP

Consumer Staples Sector SPDR

$54.51

-0.97 (-1.75%)

XLY

Consumer Discretionary Sector SPDR

$102.33

-1.75 (-1.68%)

XLB

S&P Select Materials SPDR

$51.37

-0.37 (-0.72%)

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

XLV

Health Care Select Sector SPDR

$88.99

-3.05 (-3.31%)

XLK

Technology Select Sector SPDR

$64.58

-1.6 (-2.42%)

XLI

Industrial Select Sector SPDR

$67.06

-0.95 (-1.40%)

GLD

SPDR Gold Shares

$117.10

-0.44 (-0.37%)

SLV

iShares Silver Trust

$13.69

-0.175 (-1.26%)

USO

United States Oil Fund

$10.83

-0.38 (-3.39%)

UNG

United States Natural Gas Fund

$30.78

-2.64 (-7.90%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.17

-0.365 (-0.44%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.72

-0.125 (-0.11%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

0.38 (0.32%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.57

0.19 (0.19%)

SHY

iShares 1-3 Year Treasury Bond

$83.31

0.055 (0.07%)

IWD

iShares Russell 1000 Value

$116.15

-1.71 (-1.45%)

IWF

iShares Russell 1000 Growth

$135.70

-2.96 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEI

Ecology & Environment

$11.50

0.2 (1.77%)

17:35
12/14/18
12/14
17:35
12/14/18
17:35
Hot Stocks
Ecology & Environment receives Nasdaq noncompliance notice »

On December 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$8.96

-0.045 (-0.50%)

17:34
12/14/18
12/14
17:34
12/14/18
17:34
Hot Stocks
Luther Burbank announces systematic share repurchase plan »

Luther Burbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.33

0.01 (0.76%)

17:31
12/14/18
12/14
17:31
12/14/18
17:31
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLGT

Radiant Logistics

$4.76

-0.06 (-1.24%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on Radiant Logistics »

Radiant Logistics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

17:25
12/14/18
12/14
17:25
12/14/18
17:25
Hot Stocks
POTUS names Mick Mulvaney acting WH chief of staff »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$169.87

-2.585 (-1.50%)

17:20
12/14/18
12/14
17:20
12/14/18
17:20
Hot Stocks
Raytheon awarded $149.44M Navy contract for Standard Missile-2 Block IIIC »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$100.08

-2.73 (-2.66%)

17:15
12/14/18
12/14
17:15
12/14/18
17:15
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.